You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆康醫療(002219.SZ)擬8340萬元轉讓恆康源100%股權
格隆匯 12-24 20:50

格隆匯12月24日丨恆康醫療(002219.SZ)公佈,近兩年來,由於宏觀經濟形勢嚴峻,及公司內外部情況的變化,為改善公司現金流狀況,減少負債,聚焦主業,保障公司整體健康穩定發展,根據公司年初制定的處置邊緣資產的計劃,2019年12月24日,公司與成都雅禮健康管理有限公司簽署了《四川恆康源藥業有限公司股權轉讓協議》,公司擬向受讓方轉讓公司持有的四川恆康源藥業有限公司(“恆康源”或“標的公司”)100%股權,經交易雙方參考審計報告並協商確定恆康源100%股權轉讓價款為8340萬元。

近兩年來,由於宏觀經濟形勢嚴峻,及公司內外部情況的變化,為改善公司現金流狀況,減少負債,聚焦主業,保障公司整體健康穩定發展,根據公司年初制定的處置邊緣資產的計劃公司決定出售標的公司100%股權。此次交易有利於增加公司現金流,緩解公司現金壓力,同時有利於公司和標的公司的未來發展,此次出售不會對公司本期利潤產生重大影響此次股權轉讓完成後,公司將不再持有標的公司的股權,標的公司將不再納入公司合併報表範圍

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account